Joshua Kushner is the Managing Director and founder of Thrive Capital. He serves as a Board Member at A24 Films. He serves as a Board Member at SKIMS. He co-founded Cadre (United States) & Oscar. He serves as a Board Member at Kinnek. He co-founded Vostu. He served as a Board Member at Harry's. Artsy, Groups Recover Together, Affirm, and
Zola. He is a graduate of Harvard University and earned his MBA from Harvard Business School.
Peter Barrett
Investing in Software (Web Marketplace Saas..) &b...
Hendrik Brandis is a Co-Founder and Partner of Earlybird. Hendrik's current domain focus is web-enabled services.
Hendrik is a Board Member of EVCA (European Private Equity & Venture Capital Association) and past Chairman of the EVCA Venture Capital Platform Council.
Hendrik brings together long standing investment, operational and entrepreneurial experience. Hendrik was a Board Member of element 5 AG, where he was a driving force behind the sale to Digital River (NASDAQ:DRIV), dooyoo.de AG (Berlin) which was sold to leguide.com S.A and Dianoema S.p.A., which listed on the Borsa Italiana (Milan: NOE.MI).
Hendrik currently serves on the boards of Earlybird portfolio companies B2X Care Solutions GmbH (Munich), carpooling.com GmbH (Munich), Simfy AG (Cologne) and nfon (Munich).
Hendrik gained his entrepreneurial experience as a Co-Founder of GMM, a group of private investors focusing on buy-outs of mid-sized companies and gained his operational experience as Project Manager in the Technology Department of Messerschmitt-Boelkow-Blohm (now Daimler-Chrysler Aerospace) focusing on the design and innovative manufacturing processes of composite aircraft structures.
Previously, Hendrik was a Partner with McKinsey & Co., in their Munich and Madrid offices where he led McKinsey's small and mid-sized company initiative and participated in creating McKinsey New Venture.
Hendrik attended the Technical University of Munich and holds a Dipl.-Ing. (M.Sc. equivalent) and Ph.D. degree in Aerospace Engineering.
How to connect with Angel Investors in the Life Science industry?
In the Life Science industry, angel investors such as Esther Dyson, Vinod Khosla, and Steve Jurvetson are highly active. These investors focus on startups offering innovative solutions in biotechnology, pharmaceuticals, and medical research. Esther Dyson, an entrepreneur and investor, invests in life science startups that leverage technology to advance healthcare and medical research. Vinod Khosla, founder of Khosla Ventures, looks for companies that provide groundbreaking biotech and pharmaceutical solutions. Steve Jurvetson, a co-founder of Future Ventures, seeks out startups with strong scientific foundations and significant impact potential. To connect with these investors, attend life science conferences, biotech expos, and networking events such as BIO International Convention, JP Morgan Healthcare Conference, and BioTech Week. Utilize platforms like AngelList and LinkedIn to identify and reach out to potential investors. When pitching, emphasize how your life science solution addresses key challenges, such as improving patient outcomes, advancing medical research, or developing new therapies. Highlight any traction you’ve gained, such as partnerships with research institutions, successful clinical trials, or regulatory approvals. Building relationships through initial informal meetings or discussions at industry panels can help establish trust with these investors. Demonstrating the impact of your technology through case studies or clinical results can also add credibility. Personalize your outreach by referencing the investor’s previous investments and explaining how your venture aligns with their interests. Demonstrating a sustainable business model with clear revenue streams, such as product sales, licensing, or research grants, will further strengthen your pitch. Leveraging endorsements or case studies from scientific experts can also enhance your credibility.
Case Studies: Successful Funding Rounds with Angel Investors on Angels Partners
Exotic Orange & Angels Partners: Turning Financial Simplicity Into Investment Success
